Eminence Clinical Research, Inc.
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
16.7%
1 terminated/withdrawn out of 6 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
75%
3 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Gastrointestinal Myoelectric Activity Protocol, the G-Tech EEnG Protocol
Role: collaborator
mobiCARE™ ECG Monitoring System
Role: collaborator
Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.
Role: collaborator
G-Tech Feasibility Study for Early Detection of a Post-op Ileus
Role: collaborator
Artimes Pro Low Profile Dilatation Catheters for Pre-Dilatation in Patients With Symptomatic Ischemic Heart Disease
Role: lead
Evaluation of the CloSys Closure System as an Adjunct to Standard Compression
Role: collaborator
All 6 trials loaded